XML 80 R64.htm IDEA: XBRL DOCUMENT v3.25.2
Segment Reporting - Reconciliation of Financial Measures of Segments to Consolidated Totals (Details)
$ in Millions
 1 Months Ended 3 Months Ended 6 Months Ended
Jun. 30, 2025
client
Jun. 30, 2025
USD ($)
claim
Mar. 31, 2025
USD ($)
Jun. 30, 2024
USD ($)
Jun. 30, 2025
USD ($)
Jun. 30, 2024
USD ($)
Segment Reporting Information [Line Items]            
Revenues from external customers   $ 98,428   $ 90,840 $ 192,496 $ 178,823
Net investment income (loss)   487   394 1,007 848
Total revenues   98,915   91,234 193,503 179,671
Less: Net realized capital gains (losses)   (27)   (90) (48) (108)
Cost of products sold   54,005   49,998 105,062 98,071
Health care costs   31,317   27,853 60,452 55,656
Reconciliation of principal measure of segment performance to consolidated operating income:            
Amortization of intangible assets   494   507 993 1,015
Net realized capital losses   27   90 48 108
Acquisition-related transaction and integration costs   28   102 73 162
Office real estate optimization charges   4     10  
Litigation charges   833     1,220 100
Loss on Accountable Care assets   41     288  
Operating income   2,381   3,045 5,755 5,316
Interest expense   763   732 1,548 1,448
Other income   (29)   (24) (57) (49)
Income before income tax provision   1,647   2,337 4,264 3,917
Depreciation and amortization   $ 1,171   1,151 2,325 2,289
Number of claims for which litigation charges were recorded | claim   2        
U.S. ex rel. Bassan et al. v. Omnicare, Inc. and CVS Health Corp.            
Reconciliation of principal measure of segment performance to consolidated operating income:            
Litigation charges   $ 542 $ 387      
United States Ex Rel. Behnke v. CVS Caremark Corporation, Et Al.            
Reconciliation of principal measure of segment performance to consolidated operating income:            
Litigation charges   291        
Number of clients | client 2          
Health Care Benefits            
Segment Reporting Information [Line Items]            
Revenues from external customers   35,831   32,157 70,236 64,022
Net investment income (loss)   407   300 794 653
Reconciliation of principal measure of segment performance to consolidated operating income:            
Depreciation and amortization   419   397 824 789
Health Services            
Segment Reporting Information [Line Items]            
Revenues from external customers   40,118   38,694 78,214 75,160
Net investment income (loss)   (3)   (2) 11 (2)
Reconciliation of principal measure of segment performance to consolidated operating income:            
Loss on Accountable Care assets   41     288  
Depreciation and amortization   260   264 521 525
Pharmacy & Consumer Wellness            
Segment Reporting Information [Line Items]            
Revenues from external customers   22,466   19,974 44,019 39,612
Net investment income (loss)   0   0 0 0
Reconciliation of principal measure of segment performance to consolidated operating income:            
Depreciation and amortization   389   389 773 777
Corporate/ Other            
Segment Reporting Information [Line Items]            
Revenues from external customers   13   15 27 29
Net investment income (loss)   83   96 202 197
Reconciliation of principal measure of segment performance to consolidated operating income:            
Depreciation and amortization   103   101 207 198
Intersegment Eliminations            
Segment Reporting Information [Line Items]            
Net investment income (loss)   0   0 0 0
Total revenues   (17,473)   (13,361) (33,202) (26,285)
Intersegment Eliminations | Health Care Benefits            
Segment Reporting Information [Line Items]            
Total revenues   (20)   (18) (38) (36)
Intersegment Eliminations | Health Services            
Segment Reporting Information [Line Items]            
Total revenues   (6,338)   (3,479) (11,690) (7,298)
Intersegment Eliminations | Pharmacy & Consumer Wellness            
Segment Reporting Information [Line Items]            
Total revenues   (11,115)   (9,864) (21,474) (18,951)
Operating Segments and Corporate/ Other            
Segment Reporting Information [Line Items]            
Total revenues   116,388   104,595 226,705 205,956
Adjusted operating income (loss)   3,808   3,744 8,387 6,701
Operating Segments | Health Care Benefits            
Segment Reporting Information [Line Items]            
Net investment income (loss)   407   300 794 653
Total revenues   36,258   32,475 71,068 64,711
Less: Net realized capital gains (losses)   (13)   (71) (34) (81)
Cost of products sold   0   0 0 0
Health care costs   30,740   27,458 59,377 54,916
Other segment items   4,223   4,150 8,424 8,206
Adjusted operating income (loss)   1,308   938 3,301 1,670
Reconciliation of principal measure of segment performance to consolidated operating income:            
Net realized capital losses   13   71 34 81
Operating Segments | Health Services            
Segment Reporting Information [Line Items]            
Net investment income (loss)   (3)   (2) 11 (2)
Total revenues   46,453   42,171 89,915 82,456
Less: Net realized capital gains (losses)   0   0 15 0
Cost of products sold   43,080   38,765 83,195 76,297
Health care costs   1,101   791 2,148 1,492
Other segment items   697   700 1,379 1,389
Adjusted operating income (loss)   1,575   1,915 3,178 3,278
Reconciliation of principal measure of segment performance to consolidated operating income:            
Net realized capital losses   0   0 (15) 0
Co-payments   2,700   2,800 6,400 6,200
Operating Segments | Pharmacy & Consumer Wellness            
Segment Reporting Information [Line Items]            
Net investment income (loss)   0   0 0 0
Total revenues   33,581   29,838 65,493 58,563
Less: Net realized capital gains (losses)   0   0 0 0
Cost of products sold   27,554   23,835 53,358 46,595
Health care costs   0   0 0 0
Other segment items   4,689   4,760 9,484 9,548
Adjusted operating income (loss)   1,338   1,243 2,651 2,420
Reconciliation of principal measure of segment performance to consolidated operating income:            
Net realized capital losses   0   0 0 0
Corporate/ Other | Corporate/ Other            
Segment Reporting Information [Line Items]            
Net investment income (loss)   83   96 202 197
Total revenues   96   111 229 226
Less: Net realized capital gains (losses)   (14)   (19) (29) (27)
Cost of products sold   0   0 0 0
Health care costs   40   46 86 93
Other segment items   483   436 915 827
Adjusted operating income (loss)   (413)   (352) (743) (667)
Reconciliation of principal measure of segment performance to consolidated operating income:            
Net realized capital losses   $ 14   $ 19 $ 29 $ 27